The massive building rises from the woods behind a bustling suburban market, its sleek lines and imposing facade offset by the hip-high weeds and abandoned paint buckets that line its perimeter.
This three-story, $33 million edifice once held the promise of high-paying jobs in a field that could change the very face of world health care. Now, it sits empty and idle, mired in allegations of fraud and theft.
A sign in the darkened lobby welcomes visitors to the future headquarters of GenPhar Inc., a biopharmaceutical company where workers “strive for a better human life.”
But it’s unlikely that GenPhar’s scientists ever will grace the building’s sprawling, marble-lined corridors. A bank is looking to foreclose on the place — if the federal government doesn’t snatch it up first to recoup millions of dollars in missing grant money.
Ref and Read more: http://www.postandcourier.com/news/2011/sep/26/genphar-fast-start-rapid-descent/